Structures by: Jacobs A.
Total: 70
9-(4-methoxyphenyl)-9H-xanthen-9-ol m-xylene clathrate
C20H16O3.C4H5
Organic & biomolecular chemistry (2005) 3, 7 1319-1322
a=8.4150(2)Å b=18.2852(3)Å c=12.7741(4)Å
α=95.6370(10)° β=94.9190(10)° γ=109.7170(10)°
9-(4-methoxyphenyl)-9H-xanthen-9-ol p-xylene clathrate
C20H16O3.C4H5
Organic & biomolecular chemistry (2005) 3, 7 1319-1322
a=8.3773(2)Å b=9.1657(3)Å c=12.7261(4)Å
α=94.8100(10)° β=96.3740(10)° γ=108.9480(10)°
9-(4-methoxyphenyl)-9H-xanthen-9-ol p-xylene clathrate
C20H16O3.C4H5
Organic & biomolecular chemistry (2005) 3, 7 1319-1322
a=8.3762(2)Å b=9.1588(3)Å c=12.7193(4)Å
α=94.8930(10)° β=96.4010(10)° γ=108.8720(10)°
9-(4-methoxyphenyl)-9H-xanthen-9-ol benzene clathrate
C20H16O3.C3H3
Organic & biomolecular chemistry (2005) 3, 7 1319-1322
a=8.37630(10)Å b=9.0965(2)Å c=12.6943(3)Å
α=97.4850(10)° β=104.1640(10)° γ=109.3880(10)°
9-(4-methoxyphenyl)-9H-xanthen-9-ol benzene clathrate
C20H16O3.C3H3
Organic & biomolecular chemistry (2005) 3, 7 1319-1322
a=8.3719(4)Å b=9.1093(5)Å c=12.6935(7)Å
α=97.482(2)° β=103.946(2)° γ=109.425(3)°
9-(4-methoxyphenyl)-9H-xanthen-9-ol benzene clathrate
C20H16O3.C3H3
Organic & biomolecular chemistry (2005) 3, 7 1319-1322
a=8.37570(10)Å b=9.10040(10)Å c=12.6928(2)Å
α=97.5410(10)° β=104.0530(10)° γ=109.4050(10)°
9-(4-methoxyphenyl)-9H-xanthen-9-ol o-xylene clathrate
C20H16O3.C4H5
Organic & biomolecular chemistry (2005) 3, 7 1319-1322
a=8.36540(10)Å b=9.06520(10)Å c=12.8730(3)Å
α=96.6960(10)° β=94.0480(10)° γ=109.7170(10)°
9-(4-methoxyphenyl)-9H-xanthen-9-ol m-xylene clathrate
C20H16O3.C4H5
Organic & biomolecular chemistry (2005) 3, 7 1319-1322
a=8.49020(10)Å b=9.19230(10)Å c=12.9946(2)Å
α=95.6200(10)° β=94.8400(10)° γ=109.6600(10)°
Tetra(3-hydroxy-3,3-diphenyl-2-propynyl)ethene.4(acetone) clathrate
C62H44O4.4(C3H6O)
Organic & biomolecular chemistry (2006) 4, 12 2452-2457
a=13.8204(2)Å b=13.9878(3)Å c=16.6312(3)Å
α=90.697(1)° β=91.861(1)° γ=109.789(1)°
Tetra(3-hydroxy-3,3-diphenyl-2-propynyl)ethene.2(1,4-dioxane) clathrate
C62H44O4.2(C4H8O2)
Organic & biomolecular chemistry (2006) 4, 12 2452-2457
a=8.6664(2)Å b=12.6143(2)Å c=13.1928(3)Å
α=99.167(1)° β=105.288(1)° γ=99.795(1)°
Tetra(3-hydroxy-3,3-diphenyl-2-propynyl)ethene.4(1,4-dioxane) clathrate
C62H44O4.4(C4H8O2)
Organic & biomolecular chemistry (2006) 4, 12 2452-2457
a=9.2037(3)Å b=12.8577(4)Å c=14.3892(5)Å
α=81.503(1)° β=82.891(1)° γ=79.766(1)°
Tetra(3-hydroxy-3,3-diphenyl-2-propynyl)ethene.4(dimethyl sulphoxide) clathrate
C62H44O4.4(C2H6OS)
Organic & biomolecular chemistry (2006) 4, 12 2452-2457
a=9.0698(3)Å b=13.7712(4)Å c=13.9901(5)Å
α=71.818(1)° β=71.441(1)° γ=73.849(1)°
Tetra(3-hydroxy-3,3-diphenyl-2-propynyl)ethene.5(pyridine) clathrate
C62H44O4.5(C5H5N)
Organic & biomolecular chemistry (2006) 4, 12 2452-2457
a=14.0976(2)Å b=16.7074(2)Å c=17.3826(3)Å
α=63.050(1)° β=87.506(1)° γ=70.950(1)°
9-(4-methoxyphenyl)-9H-xanthen-9-ol acridine clathrate
C20H16O3.C13H9N1
New Journal of Chemistry (2009) 33, 9 1960
a=10.607(2)Å b=11.247(2)Å c=11.967(2)Å
α=96.17(3)° β=110.43(3)° γ=111.08(3)°
9-(4-methoxyphenyl)-9H-xanthen-9-ol triethylenediamine clathrate
C20H16O3.C3H6N1
New Journal of Chemistry (2009) 33, 9 1960
a=9.0572(18)Å b=9.6751(19)Å c=10.501(2)Å
α=88.56(3)° β=83.74(3)° γ=85.45(3)°
9-(4-methoxyphenyl)-9H-xanthen-9-ol 8-hydroxyquinoline clathrate
C20H16O3.C4H3NO0.5
New Journal of Chemistry (2009) 33, 9 1960
a=8.3982(17)Å b=8.9905(18)Å c=12.954(3)Å
α=96.36(3)° β=91.64(3)° γ=109.14(3)°
9-(4-methoxyphenyl)-9H-xanthen-9-ol 1-naphthylamine clathrate
C20H16O3.C5H5N0.5
New Journal of Chemistry (2009) 33, 9 1960
a=8.4231(17)Å b=9.0634(18)Å c=13.014(3)Å
α=96.60(3)° β=91.87(3)° γ=109.87(3)°
1,1,6,6-tetraphenylhexa-2,4-diyne-1,6-diol dimethyl formamide clathrate
C30H22O2.2(C3H7NO)
CrystEngComm (2003) 5, 28 150
a=11.564(2)Å b=16.393(3)Å c=16.793(3)Å
α=90.00° β=90.00° γ=90.00°
1,1,6,6-tetraphenylhexa-2,4-diyne-1,6-diol dimethylsulphoxide clathrate
C30H22O2.2(C2H6SO)
CrystEngComm (2003) 5, 28 150
a=11.377(2)Å b=15.982(3)Å c=16.191(3)Å
α=90.00° β=90.00° γ=90.00°
1, 4-bis (diphenylhydroxymethyl) benzene dimethylacetamide clathrate
C40H44N2O4
CrystEngComm (2011) 13, 23 7014
a=11.2630(6)Å b=16.4363(8)Å c=17.4733(9)Å
α=90.00° β=90.00° γ=90.00°
1, 4-bis (diphenylhydroxymethyl) benzene dimethylacetamide clathrate polymorph
C40H44N2O4
CrystEngComm (2011) 13, 23 7014
a=12.263(3)Å b=13.918(3)Å c=11.155(2)Å
α=90.00° β=115.55(3)° γ=90.00°
1, 4-bis (diphenylhydroxymethyl) benzene dimethylformamide clathrate
C38H40N2O4
CrystEngComm (2011) 13, 23 7014
a=7.6923(11)Å b=9.1752(13)Å c=12.7495(18)Å
α=77.960(3)° β=76.026(3)° γ=66.760(2)°
1, 4-bis (diphenylhydroxymethyl) benzene N-methylacetamide clathrate
C38H40N2O4
CrystEngComm (2011) 13, 23 7014
a=7.5460(12)Å b=26.221(4)Å c=9.1335(13)Å
α=90.00° β=113.272(2)° γ=90.00°
1, 4-bis (diphenylhydroxymethyl) benzene dihydrate
C32H30O4
CrystEngComm (2011) 13, 23 7014
a=10.3078(6)Å b=10.8225(6)Å c=11.6724(6)Å
α=77.501(2)° β=77.6420(10)° γ=88.4400(10)°
1, 4-bis (diphenylhydroxymethyl) benzene N-methylformamide clathrate
C34H31NO3
CrystEngComm (2011) 13, 23 7014
a=8.2760(17)Å b=8.9920(18)Å c=18.972(4)Å
α=84.68(3)° β=89.23(3)° γ=67.92(3)°
Propylammonium deoxycholate acetone clathrate
C30H55NO5
CrystEngComm (2013) 15, 5 931
a=11.0361(11)Å b=7.7101(7)Å c=17.9654(18)Å
α=90.00° β=105.750(2)° γ=90.00°
Di-n-butylammonium deoxycholate
C32H59NO4
CrystEngComm (2013) 15, 5 931
a=14.043(3)Å b=7.8258(16)Å c=14.055(3)Å
α=90.00° β=100.94(3)° γ=90.00°
(S)-2-butylammonium deoxycholate
C28H51NO4
CrystEngComm (2013) 15, 5 931
a=10.1547(11)Å b=7.5678(8)Å c=17.645(2)Å
α=90.00° β=90.915(3)° γ=90.00°
(R)-3-methyl-2-butylammonium deoxycholate
C29H53NO4
CrystEngComm (2013) 15, 5 931
a=11.501(2)Å b=7.7042(15)Å c=17.175(3)Å
α=90.00° β=106.19(3)° γ=90.00°
(S)-3-methyl-2-butylammonium deoxycholate
C29H53NO4
CrystEngComm (2013) 15, 5 931
a=11.026(2)Å b=7.5245(15)Å c=17.600(4)Å
α=90.00° β=105.26(3)° γ=90.00°
Di-(propylammonium deoxycholate) hydrate
C54H106.26N2O12.3
CrystEngComm (2013) 15, 5 931
a=7.7287(6)Å b=11.5210(9)Å c=16.5589(13)Å
α=81.143(2)° β=79.051(2)° γ=89.485(2)°
1,1,2,2-tetraphenylethane-1,2-diol . 2(tetrahydrofuran)
C26H22O2.2(C4H8O)
CrystEngComm (2009) 11, 11 2332
a=9.2973(19)Å b=18.077(4)Å c=16.677(3)Å
α=90.00° β=92.36(3)° γ=90.00°
1,1,2,2-tetraphenylethane-1,2-diol . 2(N,N-dimethylacetamide)
C26H22O2.2(C4H9NO)
CrystEngComm (2009) 11, 11 2332
a=9.418(2)Å b=17.609(4)Å c=18.846(4)Å
α=94.39(3)° β=102.14(3)° γ=103.64(3)°
1,1,2,2-tetraphenylethane-1,2-diol. 1.5(N,N- dimethylacetamide). 0.5(tetrahydrofuran)
C26H22O2.1.5(C4H9NO).0.5(C3H7NO)
CrystEngComm (2009) 11, 11 2332
a=9.4758(19)Å b=17.394(4)Å c=18.878(4)Å
α=93.91(3)° β=102.08(3)° γ=104.66(3)°
1,4-Di-(5H-dibenzo[a,d]cyclohepten-5-ol)-buta-1,3-diyne acetone inclusion compound
C34H22O2.2(C3H6O)
CrystEngComm (2008) 10, 3 322
a=12.964(3)Å b=10.681(2)Å c=22.543(5)Å
α=90.00° β=96.89(3)° γ=90.00°
1,4-Di-(5H-dibenzo[a,d]cyclohepten-5-ol)-buta-1,3-diyne pyridine inclusion compound
C34H22O2.2(C5H5N)
CrystEngComm (2008) 10, 3 322
a=12.037(2)Å b=8.1743(16)Å c=16.658(3)Å
α=90.00° β=98.95(3)° γ=90.00°
(R)-2-butylammonium deoxycholate
C28H51NO4
CrystEngComm (2013) 15, 5 931
a=23.511(4)Å b=7.6318(12)Å c=18.196(3)Å
α=90.00° β=123.03(2)° γ=90.00°
9-(3-methoxyphenyl)-9H-xanthen-9-ol aniline clathrate
C20H16O3.C6H7N1
CrystEngComm (2005) 7, 120 731
a=13.501(3)Å b=8.8328(18)Å c=17.207(3)Å
α=90.00° β=99.32(3)° γ=90.00°
9-(4-methoxyphenyl)-9H-xanthen-9-ol aniline clathrate
C20H16O3.C3H3.5N0.5
CrystEngComm (2005) 7, 120 731
a=8.4657(17)Å b=9.1803(18)Å c=12.904(3)Å
α=95.69(3)° β=99.32(3)° γ=112.12(3)°
(bis)vanillic acid (bis)isonicotinamide dihydrate
C14H16N2O6
CrystEngComm (2015) 17, 1 98
a=7.9000(16)Å b=13.196(3)Å c=13.735(3)Å
α=85.02(3)° β=85.32(3)° γ=78.68(3)°
(bis) vanillic acid (bis) urea
C9H12N2O5
CrystEngComm (2015) 17, 1 98
a=6.9821(14)Å b=10.232(2)Å c=15.388(3)Å
α=99.68(3)° β=95.37(3)° γ=103.46(3)°
Vanillic acid (bis) caffeine co-crystal
C24H28N8O8
CrystEngComm (2015) 17, 1 98
a=10.110(2)Å b=10.525(2)Å c=12.221(2)Å
α=77.69(3)° β=81.26(3)° γ=82.69(3)°
Vanillic acid theobromine co-crystal dihydrate
C15H20N4O8
CrystEngComm (2015) 17, 1 98
a=8.2148(16)Å b=8.2504(17)Å c=13.132(3)Å
α=102.82(3)° β=97.46(3)° γ=93.98(3)°
Vanillic acid acridine co-crystal
C21H17NO4
CrystEngComm (2015) 17, 1 98
a=8.4690(17)Å b=22.621(5)Å c=8.9534(18)Å
α=90.00° β=90.68(3)° γ=90.00°
Vanillic acid nicotinamide co-crystal
C14H14N2O5
CrystEngComm (2015) 17, 1 98
a=4.8723(10)Å b=8.0058(16)Å c=18.018(4)Å
α=78.85(3)° β=84.50(3)° γ=75.62(3)°
6-hydroxy-2-naphthoic acid 1,4-dioxane solvate
C11H8O3.0.5(C4H8O2)
CrystEngComm (2010) 12, 10 3065
a=7.4451(4)Å b=5.9568(3)Å c=24.7267(13)Å
α=90.00° β=96.3190(10)° γ=90.00°
6-hydroxy-2-naphthoic acid dimethyl sulphoxide solvate
2C11H8O3.C2H6SO
CrystEngComm (2010) 12, 10 3065
a=9.4013(10)Å b=10.0069(11)Å c=12.2414(13)Å
α=95.150(2)° β=109.037(2)° γ=90.332(2)°
6-hydroxy-2-naphthoic acid 1,4-diazabicyclo[2.2.2]octane salt
2C11H8O3.2C6H12N2.3H20
CrystEngComm (2010) 12, 10 3065
a=9.1880(18)Å b=10.003(2)Å c=35.207(7)Å
α=90.00° β=91.23(3)° γ=90.00°
1-hydroxy-2-naphthoic acid 1,4-diazabicyclo[2.2.2]octane salt
2C11H8O3.C6H12N2
CrystEngComm (2010) 12, 10 3065
a=10.768(2)Å b=24.064(5)Å c=9.5656(19)Å
α=90.00° β=100.12(3)° γ=90.00°
2C11H8O3.C6H12N2
C28H28N2O6
CrystEngComm (2010) 12, 10 3065
a=8.6982(17)Å b=11.373(2)Å c=11.820(2)Å
α=85.52(3)° β=81.69(3)° γ=87.04(3)°
Di-ethylammonium-1,1'-binaphthyl-2,2'-dicarboxylate
C30H36N2O4
CrystEngComm (2014) 16, 12 2462
a=17.416(4)Å b=11.358(2)Å c=13.740(3)Å
α=90.00° β=92.41(3)° γ=90.00°
Di-n-butylammonium-1,1'-binaphthyl-2,2'-dicarboxylate
C38H52N2O4
CrystEngComm (2014) 16, 12 2462
a=9.5427(19)Å b=12.417(3)Å c=15.396(3)Å
α=81.62(3)° β=79.45(3)° γ=75.37(3)°
Di-n-butylammonium-1,1'-binaphthyl-2,2'-dicarboxylate
C38H52N2O4
CrystEngComm (2014) 16, 12 2462
a=11.8142(13)Å b=12.3251(14)Å c=13.3363(15)Å
α=64.614(2)° β=86.613(2)° γ=83.622(2)°
C53H81N5O7
C53H81N5O7
CrystEngComm (2014) 16, 12 2462
a=14.254(3)Å b=14.900(3)Å c=15.067(3)Å
α=100.82(3)° β=117.76(3)° γ=104.12(3)°
Dicyclohexylammonium-1,1'-binaphthyl-2,2'-dicarboxylate methanol hydrate
C47H66N2O6
CrystEngComm (2014) 16, 12 2462
a=13.970(3)Å b=19.964(4)Å c=15.127(3)Å
α=90.00° β=97.88(3)° γ=90.00°
2-(2,3-dimethylphenyl)aminobenzoic acid 4-methylpyridine solvate
C21H22N2O2
Acta Crystallographica Section B (2016) 72, 6 836-845
a=7.5271(15)Å b=7.5702(15)Å c=15.664(3)Å
α=88.11(3)° β=78.41(3)° γ=89.20(3)°
2-[(3-chloro-2-methylphenyl)amino]benzoic acid) 2-methylpyridine solvate
C20H19ClN2O2
Acta Crystallographica Section B (2016) 72, 6 836-845
a=7.7585(16)Å b=8.0699(16)Å c=28.056(6)Å
α=90.00° β=97.29(3)° γ=90.00°
2-[(3-chloro-2-methylphenyl)amino]benzoic acid) 3-methylpyridine solvate
C20H19ClN2O2
Acta Crystallographica Section B (2016) 72, 6 836-845
a=7.8069(16)Å b=13.987(3)Å c=32.185(6)Å
α=90.00° β=90.00° γ=90.00°
2-(2,3-dimethylphenyl)aminobenzoic acid 2methylpyridine solvate form II
C21H22N2O2
Acta Crystallographica Section B (2016) 72, 6 836-845
a=7.7857(16)Å b=8.1859(16)Å c=27.953(6)Å
α=90.00° β=96.87(3)° γ=90.00°
2-(2,3-dimethylphenyl)aminobenzoic acid 2-methylpyridine solvate form I
C21H22N2O2
Acta Crystallographica Section B (2016) 72, 6 836-845
a=7.6021(15)Å b=8.4538(17)Å c=15.375(3)Å
α=88.99(3)° β=84.05(3)° γ=64.75(3)°
2-(2,3-dimethylphenyl)aminobenzoic acid 3-methylpyridine solvate
C21H22N2O2
Acta Crystallographica Section B (2016) 72, 6 836-845
a=7.6738(6)Å b=7.7598(6)Å c=16.2725(12)Å
α=78.9570(10)° β=83.673(2)° γ=65.0940(10)°
2-(2,3-dimethylphenyl)aminobenzoic acid 3-chloropyridine solvate
C20H19ClN2O2
Acta Crystallographica Section B (2016) 72, 6 836-845
a=7.6718(15)Å b=7.7441(15)Å c=16.056(3)Å
α=80.06(3)° β=84.88(3)° γ=65.50(3)°
9-(1-naphthyl)-9H-xanthen-9-ol acetone solvate
C23H16O2,C3H6O
Acta Crystallographica Section E (2006) 62, 2 o825-o827
a=11.580(2)Å b=9.7036(19)Å c=17.489(4)Å
α=90° β=90.70(3)° γ=90°
9-Methoxy-9-(2-methoxyphenyl)-9<i>H</i>-xanthene
C21H18O3
Acta Crystallographica Section E (2012) 68, 10 o2854
a=8.0665(6)Å b=9.7653(7)Å c=21.3191(15)Å
α=90.00° β=105.560(2)° γ=90.00°
Bi13I2S18
Bi13I2S18
Chemistry of Materials (2017)
a=15.612(2)Å b=15.612(2)Å c=4.0168(6)Å
α=90° β=90° γ=120°
Bi12.67I2S18
Bi12.67I2S18
Chemistry of Materials (2017)
a=15.612(2)Å b=15.612(2)Å c=4.0168(6)Å
α=90° β=90° γ=120°
9-(4-methoxyphenyl)-9H-xanthen-9-ol dimethylforamide clathrate
C20H16O3.C3H7N1O1
Crystal Growth & Design (2007) 7, 6 1003
a=9.0685(18)Å b=9.6815(19)Å c=12.311(3)Å
α=72.36(3)° β=73.95(3)° γ=78.05(3)°
9-(4-methoxyphenyl)-9H-xanthen-9-ol cyclohexane clathrate
C20H16O3.C3H6
Crystal Growth & Design (2007) 7, 6 1003
a=8.4834(17)Å b=9.1242(18)Å c=12.712(3)Å
α=96.10(3)° β=104.73(3)° γ=110.41(3)°
9-(4-methoxyphenyl)-9H-xanthen-9-ol dioxane clathrate
C20H16O3.C2H4O1
Crystal Growth & Design (2007) 7, 6 1003
a=8.4075(17)Å b=9.0908(18)Å c=12.442(3)Å
α=97.04(3)° β=101.33(3)° γ=111.15(3)°
(bis) vanillic acid theophylline co-crystal
C23H23N4O10
CrystEngComm (2015) 17, 1 98
a=11.2741(6)Å b=15.7712(10)Å c=13.3746(8)Å
α=90.00° β=90.572(2)° γ=90.00°